Literature DB >> 1624279

Dexamethasone suppression test, melatonin and TRH-test in cluster headache.

M Leone1, F Frediani, D D'Amico, G Patruno, S Valentini, E A Parati, G Bussone.   

Abstract

The origin of Cluster Headache (CH) is still unknown. The periodicty and presence of symptoms due to both sympathetic and parasympathetic activity suggest the involvement of central nervous system structures, particularly the hypothalamus. To investigate hypothalamic involvement in CH, we employed a neuroendocrinological approach. We observed a normal dexamethasone suppression test (DST) in all patients, increased cortisol plasma levels in remission patients at 8.00am before and at the end of the DST, while only in CH patients during cluster period did we find a reduced TSH response to TRH and a reduced night-time melatonin peak. The neuroendocrinological derangements found in CH may be consistent with hypothalamic involvement.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624279     DOI: 10.1007/bf02224394

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  13 in total

1.  Comparison of the effects of pulsatile and continuous TRH infusion on TSH release in men.

Authors:  J M Hartnell; A E Pekary; J M Hershman
Journal:  Metabolism       Date:  1987-09       Impact factor: 8.694

2.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

3.  Impaired cardiovascular reflexes in cluster headache and migraine patients: evidence for an autonomic dysfunction.

Authors:  A Boiardi; L Munari; I Milanesi; C Paggetta; E Lamperti; G Bussone
Journal:  Headache       Date:  1988-07       Impact factor: 5.887

4.  Dexamethasone suppression test in cluster headache.

Authors:  J L Devoize; F Rigal; A Eschalier; M Tournilhac
Journal:  Headache       Date:  1986-03       Impact factor: 5.887

5.  Brainstem auditory evoked potential (BAEPs) in cluster headache (CH): new aspects for a central theory.

Authors:  G Bussone; M G Sinatra; A Boiardi; F Frediani; L La Mantia; E Lamperti; C Peccarisi
Journal:  Headache       Date:  1986-02       Impact factor: 5.887

6.  Changes in the 24-hour prolactin pattern in cluster headache.

Authors:  A Polleri; G Nappi; G Murialdo; G Bono; E Martignoni; F Savoldi
Journal:  Cephalalgia       Date:  1982-03       Impact factor: 6.292

7.  Cluster headache pathogenesis: a pupillometric study.

Authors:  R Salvesen; A Bogucki; M M Wysocka-Bakowska; F Antonaci; T A Fredriksen; O Sjaastad
Journal:  Cephalalgia       Date:  1987-12       Impact factor: 6.292

8.  A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache.

Authors:  G Chazot; B Claustrat; J Brun; D Jordan; G Sassolas; B Schott
Journal:  Cephalalgia       Date:  1984-12       Impact factor: 6.292

9.  Reduced testosterone levels in cluster headache: a stress-related phenomenon?

Authors:  F Facchinetti; G Nappi; C Cicoli; G Micieli; M Ruspa; G Bono; A R Genazzani
Journal:  Cephalalgia       Date:  1986-03       Impact factor: 6.292

10.  Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission.

Authors:  E Waldenlind; S A Gustafsson; K Ekbom; L Wetterberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

View more
  5 in total

Review 1.  Corticosteroid treatment in cluster headache: evidence, rationale, and practice.

Authors:  Robert E Shapiro
Journal:  Curr Pain Headache Rep       Date:  2005-04

Review 2.  Sleep and headache.

Authors:  K C Brennan; Andrew Charles
Journal:  Semin Neurol       Date:  2009-09-09       Impact factor: 3.420

Review 3.  The Role of Melatonin in the Treatment of Primary Headache Disorders.

Authors:  Amy A Gelfand; Peter J Goadsby
Journal:  Headache       Date:  2016-06-17       Impact factor: 5.887

Review 4.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

Review 5.  Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias.

Authors:  Diana Y Wei; Rigmor H Jensen
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.